HUMAN EPIDIDYMIS PROTEIN 4 AS BIOMARKER FOR THE DIFFERENTIATION BETWEEN PRIMARY OVARIAN CANCER AND OVARIAN METASTASES

被引：0
|
作者：
Boldingh, Q. J. J. [1 ]
Stiekema, A. [1 ]
Lok, C. A. R. [1 ]
Boot, H. [2 ]
van Driel, W. J. [1 ]
Kenter, G. G. [1 ]
Korse, C. M. [2 ]
机构：
[1] Dutch Canc Inst, Ctr Gynecol Oncol Amsterdam, Amsterdam, Netherlands
[2] Dutch Canc Inst, Antoni van Leeuwenhoek Hosp, Amsterdam, Netherlands
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2014年 / 24卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IGCSM-0869
引用
收藏
页码：280 / 281
页数：2
相关论文
共 50 条
  • [11] Postoperative human epididymis protein 4 predicts primary therapy outcome in advanced epithelial ovarian cancer
    Vallius, Tuulia
    Hynninen, Johanna
    Auranen, Annika
    Matomaki, Jaakko
    Oksa, Sinikka
    Roering, Pia
    Grenman, Seija
    TUMOR BIOLOGY, 2017, 39 (02) : 1 - 8
  • [12] Role of human epididymis protein 4 in chemoresistance and prognosis of epithelial ovarian cancer
    Lee, Seungho
    Choi, Seowon
    Lee, Yookyung
    Chung, Donghae
    Hong, Suntaek
    Park, Nohhyun
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2017, 43 (01) : 220 - 227
  • [13] The Human epididymis protein 4 (HE4) as a marker of ovarian cancer recurrence
    Michienzi, Simona
    Falzarano, Renato
    Viggiani, Valentina
    Rossini, Daniele
    Longo, Flavia
    Anastasi, Emanuela
    BIOCHIMICA CLINICA, 2013, 37 (03) : 195 - 199
  • [14] Human Epididymis Protein 4 (HE4) as a Serum Tumor Biomarker in Patients With Ovarian Carcinoma
    Chang, Xiaohong
    Ye, Xue
    Dong, Li
    Cheng, Hongyan
    Cheng, Yexia
    Zhu, Lirong
    Liao, Qinping
    Zhao, Yang
    Tian, Li
    Fu, Tianyun
    Chen, Jun
    Cui, Heng
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (05) : 852 - 858
  • [15] Biomarker concordance between primary colorectal cancer and ovarian metastases: a Dutch cohort study
    van der Meer, Richard
    Jeuken, Judith W. M.
    Bosch, Steven L. L.
    van Erning, Felice N. N.
    Simkens, Lieke H. J.
    de Hingh, Ignace H. J. T.
    Roumen, Rudi M. H.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (09) : 5677 - 5685
  • [16] Biomarker concordance between primary colorectal cancer and ovarian metastases: a Dutch cohort study
    Richard van der Meer
    Judith W. M. Jeuken
    Steven L. Bosch
    Felice N. van Erning
    Lieke H. J. Simkens
    Ignace H. J. T. de Hingh
    Rudi M. H. Roumen
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 5677 - 5685
  • [17] Human Epididymis Protein 4 (HE4). A tumor marker in the diagnosis of ovarian cancer
    Zulauf, N.
    Bendels, M. H.
    Bauer, J.
    Braun, M.
    Volante, G.
    Oremek, G. M.
    Groneberg, D. A.
    Brueggmann, D.
    ZENTRALBLATT FUR ARBEITSMEDIZIN ARBEITSSCHUTZ UND ERGONOMIE, 2019, 69 (01): : 30 - 32
  • [18] Clinical role of human epididymis protein 4 (HE4) in epithelial ovarian cancer
    Bandiera, E.
    Ragnoli, M.
    Zanotti, L.
    Bignotti, E.
    Romani, C.
    Tassi, R.
    Todeschini, P.
    Odicino, F.
    Ravaggi, A.
    Pecorelli, S.
    EJC SUPPLEMENTS, 2009, 7 (02): : 143 - 143
  • [19] Human epididymis secretory protein 4 in serum (HE4) as a marker of ovarian cancer
    Qu, K. Z.
    Li, H.
    Whitmire, R.
    Sferruzza, A.
    Bender, R. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [20] Transcriptional targeting in ovarian cancer cells using the human epididymis protein 4 promoter
    Berry, NB
    Cho, YM
    Harrington, MA
    Williams, SD
    Foley, J
    Nephew, KP
    GYNECOLOGIC ONCOLOGY, 2004, 92 (03) : 896 - 904
12345